Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target AMHR-II (clone 1G2EG4I). We employs the Lentivirus (SV40-GFP-TFIIB-XbaI) vector components and the SynExpress system of the Exons Inversion/Balancing feedback for a robust and sustained response against cancers.
Host
Humanized
Target
AMHR-II
Clone
1G2EG4I
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
SV40
Effector Gene
TFIIB
Insertion Sites
XbaI
Gene Modification
Inversion
Modification Domain
Exons
Carrier Type
Lentivirus
Transformation Accuracy
0.93
Cell Culture
Microcarrier Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.